JPS604190A - Preparation of cephalosporin derivative - Google Patents

Preparation of cephalosporin derivative

Info

Publication number
JPS604190A
JPS604190A JP58111537A JP11153783A JPS604190A JP S604190 A JPS604190 A JP S604190A JP 58111537 A JP58111537 A JP 58111537A JP 11153783 A JP11153783 A JP 11153783A JP S604190 A JPS604190 A JP S604190A
Authority
JP
Japan
Prior art keywords
compound
group
lower alkyl
benzylideneimino
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58111537A
Other languages
Japanese (ja)
Inventor
Junichi Nakazawa
中沢 準一
Masanao Kaneko
金子 正直
Takeo Miyaoka
宮岡 武男
Takuo Ishihara
石原 卓夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP58111537A priority Critical patent/JPS604190A/en
Publication of JPS604190A publication Critical patent/JPS604190A/en
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Cephalosporin Compounds (AREA)

Abstract

PURPOSE:To obtain the titled compound useful as an intermediate of antibacterial agent, etc., economically in an industrial scale, by reacting a specific cephem-4-carboxylic acid compound with halogenated alkyl carboxylate or carbonate, and eliminating the protecting group from the product. CONSTITUTION:The objective compound of formula III is produced by dispersing the compound of formula I [A is amino or (substituted) benzylideneimino] (e.g. 7beta-amino-3-methoxymethyl-3-cephem-4-carboxylic acid) in a solvent such as N,N- dimethylacetamide, reacting with the compound of formula II (R<1> is H or lower alkyl; R<2> is lower alkyl or lower alkoxy; X is halogen) (e.g. 1-iodoethyl isopropylcarbonate) in the presence of a base such as diisopropylamine, and removing benzylidene group when A is benzylideneimino.

Description

【発明の詳細な説明】 本発明は一般式 (式中 11は水素原子または低級アルキル基を示し 
12は低級アルキル基または低級アルコキシ基を示す。
Detailed Description of the Invention The present invention is based on the general formula (wherein 11 represents a hydrogen atom or a lower alkyl group)
12 represents a lower alkyl group or a lower alkoxy group.

) を有するセファロスポリン誘導体及びその酸付加塩の新
規な製法に関するもので、更に詳しく一般式 (式中、Aはアミノ基または置換基を有するか有しない
ベンジリデンイミノ基を示す。)を有する化合物に塩基
の存在下、 一般式 (式中 R1およびR2は前述したものと同意義を示し
、Xは)・ログン原子を示す。)を有する化合物を反応
せしめ、Aがベンジリデンイミノ基である場合には、ベ
ンジリデン基を脱離することを特徴とする前記一般式(
1)を有する化合物及びその酸付加塩の製法に関するも
のである。
) and relates to a new method for producing cephalosporin derivatives and acid addition salts thereof, more specifically compounds having the general formula (wherein A represents an amino group or a benzylideneimino group with or without a substituent). In the presence of a base, the general formula (wherein R1 and R2 have the same meanings as described above, and X represents a rogone atom) is obtained. ), and when A is a benzylidene imino group, the benzylidene group is eliminated.
The present invention relates to a method for producing a compound having 1) and an acid addition salt thereof.

上記式中 R1は好適には水素原子またはメチル基を示
し R2はメチル、エチル、n−プロピル、イソプロピ
ル、n−ブチル、イソジチル、臓−ブチル、tert−
ブチルのような炭素数1乃至4を有する直鎖状若しくは
分枝鎖状のアルキル基またはメトキシ、エトキシ、n−
グロポキシ、インシトキシ、n−ブトキシ、インシトキ
シ、(8)−ブトキシ、tart−シトキシのような炭
素数1乃至4個を有する直鎖状若しくは分枝鎖状のアル
コキシ基を示し、Aはアミン基またはベンジリデンイミ
ノ若しくはサリチリデンイミノのような非置換若しくは
置換ベンジリデンイミノ基を示し、Xは臭素または沃素
のようなハロダン原子を示す。
In the above formula, R1 preferably represents a hydrogen atom or a methyl group, and R2 represents methyl, ethyl, n-propyl, isopropyl, n-butyl, isodityl, tert-butyl, and tert-butyl.
A linear or branched alkyl group having 1 to 4 carbon atoms such as butyl, methoxy, ethoxy, n-
It represents a linear or branched alkoxy group having 1 to 4 carbon atoms, such as glopoxy, incytoxy, n-butoxy, incytoxy, (8)-butoxy, and tart-cytoxy, and A is an amine group or benzylidene group. It represents an unsubstituted or substituted benzylideneimino group such as imino or salicylideneimino, and X represents a halodane atom such as bromine or iodine.

一般にこのような本発明の化合物の従来法による製法と
しては、セファロスポリン骨格の7位をアシル化し、つ
いで4位カルビン酸のエステル化、ついで五塩化燐等に
よるイミノエーテル法によってアシル基を切断して実施
されていた。本発明の方法によれば、このような五塩化
燐によるアシル基切断等煩雑な操作を必要とせず容易に
目的物を得る事ができる。
In general, the conventional method for producing such compounds of the present invention involves acylating the 7-position of the cephalosporin skeleton, then esterifying carbic acid at the 4-position, and then cleaving the acyl group by an iminoether method using phosphorus pentachloride or the like. It was carried out as follows. According to the method of the present invention, the desired product can be easily obtained without requiring complicated operations such as cleavage of acyl groups with phosphorus pentachloride.

本発明の方法を実施するにあたって、前記一般式(II
)を有する化合物を一般式(至)を有する化合物と塩基
の存在下で反応させるエステル化反応は、溶剤の存在下
で行なうことができる。使用される溶剤としては反応に
関与しないものであれば特に限定はないが、例えばジメ
チルホルムアミド、ジメチルアセトアミドのような脂肪
酸ジアルキルアミド類またはこれらとソクロルメタン、
メタノールのような有機溶剤との混合溶剤が好適である
。反応に使用される塩基としてはトリエチルアミン、ツ
インプロピルアミン、tart−オクチルアミン、ジメ
チル−ベンジルアミン、ジシクロヘキシルアミンのよう
な有機塩基が好適である。反応温度は通常、−10℃乃
至室温付近であシ、反応時間は反応温度、反応試剤(曲
の種類などによって異なるが、通常、30分乃至2時間
である。
In carrying out the method of the present invention, the general formula (II
) can be reacted with a compound having the general formula (-) in the presence of a base, which can be carried out in the presence of a solvent. The solvent used is not particularly limited as long as it does not participate in the reaction, but for example, fatty acid dialkylamides such as dimethylformamide and dimethylacetamide, or these together with sochloromethane,
A mixed solvent with an organic solvent such as methanol is preferred. Suitable bases used in the reaction are organic bases such as triethylamine, twinpropylamine, tart-octylamine, dimethyl-benzylamine, and dicyclohexylamine. The reaction temperature is usually around -10°C to room temperature, and the reaction time is usually 30 minutes to 2 hours, although it varies depending on the reaction temperature, reaction reagent (type of music, etc.).

本エステル化反応によって得られる化合物において、置
換基Aがベンジリデンアミノ基を表わす場合には、常法
に従ってベンジリデン基を脱離することができる。その
目的のための脱離試薬としてシッフ塩基化合物よジアミ
ノ基を再生するものであれば特に限定はないが、好適に
はジラードT試薬、フェニルヒドラジンまたはその塩酸
塩、アセテルヒドラソン、ベンゾイルヒドラジン、アニ
リン、トルイジンのような有機塩基又はそれらの酢酸ま
たはシュウ酸等の酸付加塩をあげることができる。
In the compound obtained by this esterification reaction, when substituent A represents a benzylidene amino group, the benzylidene group can be removed according to a conventional method. As an elimination reagent for that purpose, there is no particular limitation as long as it regenerates the diamino group, such as a Schiff base compound, but preferred examples include Girard T reagent, phenylhydrazine or its hydrochloride, acetelhydrazone, benzoylhydrazine, Examples include organic bases such as aniline and toluidine, and acid addition salts thereof such as acetic acid or oxalic acid.

反応終了後、本反応の目的化合物(1)は常法に従って
反応混合物から採取することができる。
After the reaction is completed, the target compound (1) of this reaction can be collected from the reaction mixture according to a conventional method.

例えば、反応混合物を酢酸エチルのような有機溶剤で抽
出し、有機溶剤層を水洗し乾燥することによって得るこ
とができる。このようにして得られた目的化合物は必要
ならば常法に従って、例えば塩酸塩、臭化水素酸塩、ベ
ンゼンスルホンTIN塩、p −)ルエンスルホン酸塩
、α−若L<iiβ−ナフタレンスルホン酸塩のような
酸付加塩として精製することができる。
For example, it can be obtained by extracting the reaction mixture with an organic solvent such as ethyl acetate, washing the organic solvent layer with water, and drying. The target compound thus obtained can be prepared, if necessary, by conventional methods, such as hydrochloride, hydrobromide, benzenesulfone TIN salt, p-)luenesulfonate, α-L<iiβ-naphthalenesulfonic acid. It can be purified as an acid addition salt such as a salt.

本発明の目的化合物(1)は、抗菌作用を有する医薬の
原料として有用である。例えば本化合物(1)を中間体
として特開昭57−59894号明細書に記載されてい
るような経口用セファロスポリン化合物を製造すること
ができる。
The object compound (1) of the present invention is useful as a raw material for pharmaceuticals having antibacterial activity. For example, an oral cephalosporin compound as described in JP-A-57-59894 can be produced using the present compound (1) as an intermediate.

次に実施例をあげて本発明の製法を更に具体的に説明す
る。
Next, the manufacturing method of the present invention will be explained in more detail with reference to Examples.

実施例 1 7β−アミノ−3−メトキシメチル−3−セフェム−4
−カルボン酸5.01をN、N−ジメチルアセトアミド
50−に懸濁し、氷水浴中5℃以下に冷却し、攪拌しな
がら、ジインプロピルアミン3.4−を加え、ついでベ
ンツアルデヒド2.5m1lを加え30分間攪拌を続け
る、透明な溶液となる。
Example 1 7β-amino-3-methoxymethyl-3-cephem-4
- 5.0 l of carboxylic acid was suspended in 50 - of N,N-dimethylacetamide, cooled to below 5°C in an ice-water bath, and while stirring, 3.4 - of diimpropylamine was added, followed by 2.5 ml of benzaldehyde. Add and continue stirring for 30 minutes, resulting in a clear solution.

これに1−ヨードエチルイソプロビルカーポネー)7.
5F!−を加え、1時間半攪拌し、ノラードT試薬7.
01をメタノール100rnlにとかした溶液を加え、
更に40分攪拌する。ついで減圧濃縮し、メタノールを
留去する。残留物に酢酸エチル100ゴを加え18%食
塩水60 ml及び20−で二回洗浄し、水層を更に酢
酸エチルが得られる。これを酢酸エチル50rnlに溶
解し、水50−を加え、攪拌しながら6NHCtを加え
−を1.8に調整し、食塩を加えると結晶が析出する。
7.
5F! - was added, stirred for 1.5 hours, and Norard T reagent 7.
Add a solution of 01 dissolved in 100rnl of methanol,
Stir for an additional 40 minutes. Then, the mixture is concentrated under reduced pressure to distill off methanol. Add 100 ml of ethyl acetate to the residue and wash twice with 60 ml of 18% brine and 20 ml of 18% brine to obtain more ethyl acetate from the aqueous layer. Dissolve this in 50rnl of ethyl acetate, add 50ml of water, add 6N HCl while stirring to adjust the - to 1.8, and add salt to precipitate crystals.

沢果し、酢酸エチルで洗浄し、乾燥すると、2.59−
の標記化合物のエビャーの一方が塩酸塩として得られた
。
When washed with ethyl acetate and dried, 2.59-
One of the title compounds was obtained as a hydrochloride.

融点186〜188℃(分解) nmrスペクトル(CD、OD)δ: 1.30 二重線(6I(、J =6Hz )1.57
 二重線(3H、J =6 Hz )3.37−重線(
3H) 3.7〇 −重線(2H) 4.40−重線(2H) 5.13 、5.30 四重量(2H、d、d 、 J
=5Hz )6.93 四重線(! H、J=6Hz 
)この塩酸塩を炉去した炉液を分液し、酢酸エチル層を
とり、5%炭酸水素ナトリウム水、ついで水で洗浄し、
p−)ルエンスルホン酸2.5Iを加えてとかし、一度
減圧濃縮乾固し、酢酸エチルを加えて放置すると結晶が
析出する。これを炉集、酢酸エチルで洗浄後乾燥すると
、3.71の標記化合物の他方のエピマーのp−)ルエ
ンスルホン酸塩が得られた。
Melting point 186-188°C (decomposed) nmr spectrum (CD, OD) δ: 1.30 Doublet (6I (, J = 6Hz) 1.57
Double line (3H, J = 6 Hz) 3.37 - Double line (
3H) 3.7〇 - Heavy line (2H) 4.40 - Heavy line (2H) 5.13 , 5.30 Four weights (2H, d, d, J
=5Hz)6.93 Quadruple (! H, J=6Hz
) The furnace liquor from which this hydrochloride was removed in the furnace was separated, the ethyl acetate layer was taken, and the layer was washed with 5% sodium bicarbonate water and then with water.
p-) Add 2.5 I of luenesulfonic acid and dissolve, once concentrate to dryness under reduced pressure, add ethyl acetate and leave to stand to precipitate crystals. This was collected in a furnace, washed with ethyl acetate, and dried to obtain p-)luenesulfonate of the other epimer of the title compound 3.71.

融点182〜183.5℃(分解) nmrスペクトル(CD、OD)δ: 1.27 二重線(6H、J =6Hz )1.53 
二重M(3H、J =6 Hz )2.37−重線(3
H) 3.37−重線(3H) 3.67−重線(2H) 4.33−重線(2H) 5.13 、5.27 四重線(2H、d、d 、 J
=5Hz )6.87 四1線(II(、J =6Hz
 )7.23 、7.73 四重線(4HIA2B2.
J=9Hz)実施例 2 7β−アミノ−3−メトキシフチルー3−セフェム−4
−カルボン酸5.Qy−をN、N−ジメチルアセトアミ
ド5o−に懸濁し、氷水浴中5℃以下に冷却し、攪拌し
なからtert−オクチルアミン4.3−を加えて溶解
せしめ、1−ヨードエチルイソプロビルヵーポネー)7
.4Fを加え2時間攪拌を続ける。ついで酢酸エテル1
00−を加え、実施例1の如く処理すると、例1の標記
化合物6.01が得られ、例1の如く同様に操作すると
、塩酸塩2.1?及びp−トルエンスルホン酸塩3.0
g−が得られた。
Melting point 182-183.5°C (decomposed) nmr spectrum (CD, OD) δ: 1.27 Doublet (6H, J = 6Hz) 1.53
Double M (3H, J = 6 Hz) 2.37-Double (3
H) 3.37-double (3H) 3.67-double (2H) 4.33-double (2H) 5.13, 5.27 quartet (2H, d, d, J
=5Hz)6.87 41st line (II(,J =6Hz
) 7.23, 7.73 quartet (4HIA2B2.
J=9Hz) Example 2 7β-amino-3-methoxyphthyl-3-cephem-4
-carboxylic acid5. Qy- was suspended in N,N-dimethylacetamide 5o-, cooled to below 5°C in an ice water bath, and while stirring, tert-octylamine 4.3- was added and dissolved, and 1-iodoethyl isopropyl chloride was added. - Pone) 7
.. Add 4F and continue stirring for 2 hours. Then ethyl acetate 1
00- and working up as in Example 1 gives 6.01 of the title compound of Example 1; working similarly as in Example 1 gives the hydrochloride 2.1? and p-toluenesulfonate 3.0
g- was obtained.

実施例 3 7β−アミノ−3−メトキシメチル−3−セフェム−4
−カルボン酸2.44fをツメチルアセトアミド25ゴ
に水冷下懸濁し、ジイソプロピルアミン1.IPを加え
てとかし、ベンツアルデヒド1.2 tdを加え30分
攪拌後ヒバロイルオキシメチルアイオダイド3.15 
Pを加え、3℃で1時間30分攪拌する。ついでジラー
ドT試薬3.4Fをメタノール50fIttにとかした
溶液を加え、1時間攪拌する。メタノールを減圧留去し
残留物に酢酸エチル60−を加え、・18%食塩水30
7!で二回洗浄後減圧濃縮し、残留物をベンゼン:酢酸
エチル(1:1)) nmrスペクトル(CDCA3)δ: 1.23−重線(9H) 3.30−重線(3■) 3.48−重線(2■) 4.23−g@(2H) 4.63 、4.87 四重線(2H、d、d 、 J
=5Hz )5.80−重線(2H) 実施例 4 実施例3のピパロイルオキシメチルアイオダイド3.1
5fの代シにヨードメチルイングロビルカーがネー)3
.2iを用い、同様に反応せしマド溶媒、ベンゼン:酢
酸エチル 1:1)nmrスペクトル(CDCA、)δ
: 1.30 二重線(2H、J=6 Hz )3.31−
重線(3H) 3.51−重線(2H) 4.71,4.98 VfAX線(2H、d、d 、 
J=5Hz )5.83−重線(2K) 実施例 5 実施例3のピパロイルオキシメチルアイオダイドの代フ
にヨードメチルエチルカーがネートnmrスペクト# 
(CDCA3)δ:1.32三重線(3H、J=7Hz
 )3.26−重線(3H) 3.50−重線(3■) 4.16 四重線(2H,J=7Hz)4.67 、4
.85 四重線(2H、d、d 、 J=5Hz )5
.80−重線(2H) 特許出願人 三共株式会社 代理人 弁理士 樫出庄治
Example 3 7β-amino-3-methoxymethyl-3-cephem-4
- 2.44f of carboxylic acid was suspended in 25g of trimethylacetamide under water cooling, and 1.4f of diisopropylamine was suspended in 25g of dimethylacetamide. Add and dissolve IP, add 1.2 td of benzaldehyde and stir for 30 minutes, then add 3.15 td of hivaloyloxymethyl iodide.
Add P and stir at 3°C for 1 hour and 30 minutes. Then, a solution of 3.4F Girard T reagent dissolved in 50fItt of methanol is added and stirred for 1 hour. Methanol was distilled off under reduced pressure, 60% of ethyl acetate was added to the residue, and 30% of 18% brine was added.
7! After washing twice with , it was concentrated under reduced pressure, and the residue was purified using benzene:ethyl acetate (1:1). 48-Double line (2■) 4.23-g@(2H) 4.63, 4.87 Quadruple line (2H, d, d, J
=5Hz) 5.80-duplex (2H) Example 4 Piparoyloxymethyl iodide of Example 3 3.1
Iodomethyl inglovir car is substituted for 5f) 3
.. 2i, reacted in the same manner as solvent, benzene:ethyl acetate 1:1) nmr spectrum (CDCA, ) δ
: 1.30 Double line (2H, J=6 Hz) 3.31-
Heavy line (3H) 3.51-Double line (2H) 4.71, 4.98 VfAX ray (2H, d, d,
J=5Hz) 5.83-double line (2K) Example 5 In place of the piparoyloxymethyl iodide of Example 3, iodomethylethyl car was used as a nate nmr spectrum #
(CDCA3) δ: 1.32 triplet (3H, J=7Hz
) 3.26-double line (3H) 3.50-double line (3■) 4.16 Quadruple line (2H, J=7Hz) 4.67, 4
.. 85 Quadruple (2H, d, d, J=5Hz) 5
.. 80-Double line (2H) Patent applicant: Sankyo Co., Ltd. Agent Patent attorney: Shoji Kashide

Claims (1)

【特許請求の範囲】 一般式 (式中、Aはアミン基または置換基を有するか有しない
ベンジリデンイミノ基を示す。)を有する化合物に塩基
の存在下、 一般式 (式中、R1は水素原子または低級アルキル基を示し 
B2は低級アルキル基または低級アルコキシ基を示し、
Xはハロダン原子を示す@)を有する化合物を反応せし
め、Aがベンジリデンイミノ基の場合には、ベンジリデ
ン基を脱離することを特徴とする 一般式 (式中 R1およびR2は前述したものと同意義を示す
。) を有するセファロスポリン誘導体及びその酸付加塩の製
法。
[Scope of Claims] In the presence of a base, a compound having the general formula (wherein A represents an amine group or a benzylideneimino group with or without a substituent) is treated with the general formula (wherein R1 is a hydrogen atom). or lower alkyl group
B2 represents a lower alkyl group or a lower alkoxy group,
A general formula (wherein R1 and R2 are the same as those described above) is reacted with a compound having @) where X represents a halodane atom, and when A is a benzylidene imino group, the benzylidene group is eliminated. A process for producing a cephalosporin derivative and an acid addition salt thereof having the following.
JP58111537A 1983-06-21 1983-06-21 Preparation of cephalosporin derivative Pending JPS604190A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58111537A JPS604190A (en) 1983-06-21 1983-06-21 Preparation of cephalosporin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58111537A JPS604190A (en) 1983-06-21 1983-06-21 Preparation of cephalosporin derivative

Publications (1)

Publication Number Publication Date
JPS604190A true JPS604190A (en) 1985-01-10

Family

ID=14563866

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58111537A Pending JPS604190A (en) 1983-06-21 1983-06-21 Preparation of cephalosporin derivative

Country Status (1)

Country Link
JP (1) JPS604190A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410042A (en) * 1992-05-21 1995-04-25 Hoechst Aktiengesellschaft Process for the cleavage of cephalosporin prodrug esters to 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid
US5461043A (en) * 1991-09-07 1995-10-24 Hoechst Aktiengesellschaft Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate
LT3870B (en) 1993-11-30 1996-04-25 Hoechst Ag Diastereomers of 3-cefem-4-carboxylic acid 1-(isopropoxy-carbonyloxy)ethyl ester, process for preparingthereof, antibacteric preparations based on same and process for preparation thereof
US5589594A (en) * 1992-02-14 1996-12-31 Hoechst Aktiengesellschaft Process for the preparation of cephem prodrug esters

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49132097A (en) * 1972-10-05 1974-12-18
JPS57169489A (en) * 1981-04-13 1982-10-19 Sankyo Co Ltd Cephalosporin derivative and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49132097A (en) * 1972-10-05 1974-12-18
JPS57169489A (en) * 1981-04-13 1982-10-19 Sankyo Co Ltd Cephalosporin derivative and its preparation

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461043A (en) * 1991-09-07 1995-10-24 Hoechst Aktiengesellschaft Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate
US5550232A (en) * 1991-09-07 1996-08-27 Hoechst Aktiengesellschaft Diastereomers of 1-(isopropoxycarbonyloxy) ethyl 3-cephem 4-carboxylate
US5614623A (en) * 1991-09-07 1997-03-25 Hoechst Aktiengesellschaft Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate and processes for their preparation
US5589594A (en) * 1992-02-14 1996-12-31 Hoechst Aktiengesellschaft Process for the preparation of cephem prodrug esters
US5637721A (en) * 1992-02-14 1997-06-10 Hoechst Aktiengesellschaft Process for the preparation of cephem prodrug esters
US5410042A (en) * 1992-05-21 1995-04-25 Hoechst Aktiengesellschaft Process for the cleavage of cephalosporin prodrug esters to 7-amino-3-methoxymethylceph-3-em-4-carboxylic acid
LT3870B (en) 1993-11-30 1996-04-25 Hoechst Ag Diastereomers of 3-cefem-4-carboxylic acid 1-(isopropoxy-carbonyloxy)ethyl ester, process for preparingthereof, antibacteric preparations based on same and process for preparation thereof

Similar Documents

Publication Publication Date Title
JPH0149271B2 (en)
JPH0362711B2 (en)
JPS5834474B2 (en) Method for producing thiazolidine derivatives
JPH05247013A (en) Novel oxime derivative of aminothiazolyl acetic acid and preparation thereof
JPS6339869A (en) Novel oxime derivative of aminothiazolylacetic acid and its production
JP3751880B2 (en) Method for producing high-purity cefpodoxime proxetil
JPH041757B2 (en)
JP4303792B2 (en) Method for producing quinolone derivative
JPS6178791A (en) Manufacture of cephem derivative
JPH0134219B2 (en)
JPH0454674B2 (en)
JPS61225183A (en) Manufacture of beta-carboline
CA1280409C (en) Method of producing cephem compounds
US5998611A (en) Process for producing cephem compounds in an aqueous medium
JPH02167289A (en) Production of novel cephalosporin derivative
JPS6052754B2 (en) 7-amino-3-halogenomethyl-△↑3-cephem-4-carboxylic acids and their production method
JPS63500721A (en) New manufacturing method for chemical compounds
JPS6324994B2 (en)
JP3495417B2 (en) Method for producing 2-alkoxy-3,5-dihalogeno-6-nitrobenzoic acids
JPS58159496A (en) Cephem-based compound
KR890000523B1 (en) Process for preparing cephalosporin derivatives
JPS643197B2 (en)
JPS6126998B2 (en)
JPS6124568A (en) Method for producing dihydropyridine ester
JPS6110569A (en) Preparation of 2-(2-aminothiazole)-acetic acid derivative